Department of Neurology, McGovern Medical School, Houston, Texas.
Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, Texas.
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104361. doi: 10.1016/j.jstrokecerebrovasdis.2019.104361. Epub 2019 Sep 9.
Spontaneous supratentorial intracerebral hemorrhage (ICH) contributes disproportionately to stroke mortality, and randomized trials of surgical treatments for ICH have not shown benefit. Decompressive hemicraniectomy (DHC) improves functional outcome in patients with malignant middle cerebral artery ischemic stroke, but data in ICH patients is limited. We hypothesized that DHC would reduce in-hospital mortality and poor functional status (defined as modified Rankin scale ≥5) among survivors at 3 months, without increased complications.
We performed a retrospective, case-control, propensity score matched study to determine whether hemicraniectomy affected outcome in patients with spontaneous supratentorial ICH. The propensity score consisted of variables associated with outcome or predictors of hemicraniectomy. Forty-three surgical patients were matched to 43 medically managed patients on ICH location, sex, and nearest neighbor matching. Three-month functional outcomes, in-hospital mortality, and in-hospital complications were measured.
In the medical management group, 72.1% of patients had poor outcome at 3 months compared with 37.2% who underwent hemicraniectomy (odds ratio 4.8, confidence interval 1.6-14). In-hospital mortality was 51.2% for medically managed patients and 16.3% for hemicraniectomy patients (odds ratio 8.5, confidence interval 2.0-36.8). There were no statistically significant differences in the occurrence of in-hospital complications.
In our retrospective study of selected patients with spontaneous supratentorial ICH, DHC resulted in lower rate of in-hospital mortality and better 3-month functional status compared with medically managed patients. A randomized trial is necessary to evaluate DHC as a treatment for certain patients with spontaneous supratentorial ICH.
自发性幕上脑出血(ICH)在卒中死亡率中占比较大,且针对 ICH 手术治疗的随机试验并未显示出获益。去骨瓣减压术(DHC)可改善恶性大脑中动脉缺血性卒中患者的功能结局,但 ICH 患者的数据有限。我们假设 DHC 可降低住院期间死亡率和 3 个月时幸存者的不良功能状态(定义为改良 Rankin 量表≥5),且不会增加并发症。
我们进行了一项回顾性病例对照倾向性评分匹配研究,以确定 DHC 是否会影响自发性幕上 ICH 患者的结局。倾向性评分由与结局相关的变量或 DHC 预测因素组成。根据 ICH 位置、性别和最近邻居匹配,将 43 例手术患者与 43 例接受药物治疗的患者进行匹配。测量 3 个月的功能结局、住院期间死亡率和住院期间并发症。
在药物治疗组中,72.1%的患者在 3 个月时预后不良,而接受 DHC 的患者中有 37.2%(优势比 4.8,95%置信区间 1.6-14)。药物治疗组的住院期间死亡率为 51.2%,DHC 组为 16.3%(优势比 8.5,95%置信区间 2.0-36.8)。两组的住院期间并发症发生率无统计学差异。
在我们对选择性自发性幕上 ICH 患者的回顾性研究中,与药物治疗组相比,DHC 可降低住院期间死亡率和改善 3 个月时的功能状态。需要进行随机试验来评估 DHC 作为某些自发性幕上 ICH 患者的治疗方法。